Orita K, Onishi N, Kunisada K, Konaga E, Kokumai Y
Acta Med Okayama. 1975 Jun;29(3):183-7.
In mouse bearing progressive cancer a decrease was present in the allogeneic inhibitory activity of T-lymphocytes, which constitutes the core of immunological surveillance system in mammalians. For tests, methylcholanthrene-induced tumor (MC-tumor) was isografted subcutaneously on the back between scapulae of C3H mice, and the lymphocytes were prepared from the regional axillary lymph nodes removed from these mice at 1, 2, 3, or 4 weeks after grafting. These lymph nodes cells were cultured together with 40-fold numbers of allogeneic JTC-11 cells derived from Ehrlich cancer cells in a culture medium containing 2.0% (v/v) PHA for 24 or 48 hours. The proliferation rate of JTC-11 cells (increased numbers) at weekly interval was considered the allogeneic inhibitory activity of lymph node cells. As a result it was demonstrated that in the early stage after tumor transplantation, i.e., in the first or second week, regional lymph node cells showed a strong allogeneic inhibitory activity, as in the case with lymph-node cells from normal mice, but at progressive stage of cancer, i.e., the third or fourth week when tumors were larger, such activity was completely lost. It seems that mice with progressive cancer showed a decrease of allogeneic inhibitory activity, i.e., a disruption of homeostasis was present.
在患有进行性癌症的小鼠中,T淋巴细胞的同种异体抑制活性降低,而T淋巴细胞是哺乳动物免疫监视系统的核心。为了进行测试,将甲基胆蒽诱导的肿瘤(MC肿瘤)同基因移植到C3H小鼠肩胛间背部皮下,在移植后1、2、3或4周,从这些小鼠切除的局部腋窝淋巴结中制备淋巴细胞。将这些淋巴结细胞与源自艾氏癌细胞的40倍数量的同种异体JTC-11细胞在含有2.0%(v/v)PHA的培养基中共同培养24或48小时。JTC-11细胞每周的增殖率(增加的数量)被视为淋巴结细胞的同种异体抑制活性。结果表明,在肿瘤移植后的早期阶段,即第一周或第二周,局部淋巴结细胞表现出很强的同种异体抑制活性,与正常小鼠的淋巴结细胞情况相同,但在癌症进展阶段,即肿瘤较大的第三周或第四周,这种活性完全丧失。似乎患有进行性癌症的小鼠表现出同种异体抑制活性降低,即存在内环境稳定的破坏。